Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain
IntroductionChronic pelvic pain affects up to 24% of women worldwide and for up to 55% of these there is no associated pathology. Despite this there are no established treatments in this cohort. This is a secondary analysis of a randomised-controlled trial (GaPP2) to explore if there are measures wh...
Saved in:
| Main Authors: | Lydia Coxon, Maryam Amer, Jane Daniels, Ann M. Doust, Scott C. Mackenzie, Andrew W. Horne, Katy Vincent |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1460206/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gabapentin Toxicity and Role of Dialysis; Case Series and Literature Review
by: Muzamil Latief, et al.
Published: (2021-12-01) -
Perbandingan Dosis Induksi dan Pemeliharaan Propofol Pada Operasi Onkologi Mayor yang Mendapatkan Pemedikasi Gabapentin dan Tanpa Gabapentin
by: Ida Bagus Okta, et al.
Published: (2017-11-01) -
Diagnosis and treatment of chronic pelvic pain syndrome
by: L. T. Akhmedzhanova, et al.
Published: (2022-08-01) -
Gabapentin Monotherapy for Refractory Seizures
by: J Gordon Millichap
Published: (1997-10-01) -
Comparison of Anticonvulsant Effects of Combined Regimens of Gabapentin and Verapamil with their Individual Effects
by: Itefaq Hussain Qureshi, et al.
Published: (2016-06-01)